FilingSEC EDGAR6-K
Addex Therapeutics Regains Global Rights to GABAB PAM Portfolio from Indivior
· SEC accepted
StageClinical-stage
Filing content
Addex Therapeutics announced it has regained full global rights to its GABAB PAM portfolio following Indivior's R&D rationalization.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…